Home > List All Publishers > Pharmspective

Pharmspective

Pharmspective, LLC is a Specialty Therapeutics Market Research firm providing commercial insights and knowledge management applications for the biopharmaceutical industry. The company is uniquely focused on understanding the buying process for specialty therapeutics through syndicated market research studies examining clinical decision-making, drug acquisition, access and reimbursement, and therapy administration for specialty therapeutics in autoimmune diseases and Oncology. Pharmspective's Healthcare Reform team provides insights into the Affordable Care Act through its proprietary ClearView knowledge management application, market assessments of the impact of key ACA provisions on healthcare decision-makers, and its HealthCareReformInsider website. The company maintains offices in New York City and St. Louis, MO.

List of reports from Pharmspective

Healthcare Reform: State Exchanges-Opportunities and Threats for Key Health Insurers and Pharmaceutical Manufacturers 10/1/2012 \| published by: Pharmspective ... to compete in a post-Affordable Care Act era. Changes to the market access landscape facing pharmaceutical manufacturers in the U.S. are the foundation for this new Pharmspective research report, which provides a detailed look at ... \| more... Search inside this report	$22,000.00
Healthcare Reform: Texas-State Exchanges and Medicaid Expansion Implications for Key Health Insurers and Pharmaceutical Manufacturers 10/1/2012 \| published by: Pharmspective ... the Affordable Care Act. With the largest uninsured population in the country, Texas is likely to see significant competition for this group once the political rhetoric subsides. The large Medicaid influx will certainly impact access ... \| more... Search inside this report	$4,500.00
Healthcare Reform: California-State Exchanges and Medicaid Expansion Implications for Key Health Insurers and Pharmaceutical Manufacturers 10/1/2012 \| published by: Pharmspective ... low managed care penetration. California is likely to have one of the most robust State Exchanges in the post-ACA landscape as it leads the nation in developing the required infrastructure to implement the new insurance ... \| more... Search inside this report	$4,500.00
Healthcare Reform: New York-State Exchanges and Medicaid Expansion Implications for Key Health Insurers and Pharmaceutical Manufacturers 10/1/2012 \| published by: Pharmspective ... with low managed care penetration. New York’s transition to Managed Medicaid and the void of insurers within the small group market in the state set the stage for significant competition for new eligibles expected to ... \| more... Search inside this report	$4,500.00
Psoriasis Pipeline Perspectives Report - Intracellular Signaling Blockers 7/1/2012 \| published by: Pharmspective ... are being actively pursued by manufacturers. Psoriasis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for Psoriasis by pathway target and mechanism of action. Pipeline Analysis by Pathway Target and Mechanism ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - Direct Inflammatory Cytokine Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$2,250.00
Rheumatoid Arthritis Pipeline Perspectives Report - T-cell Activation Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - Intracellular Signaling Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - Non-Lymphocytic Inflammatory Cell Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$8,500.00
Psoriasis Pipeline Perspectives Report 7/1/2012 \| published by: Pharmspective ... are being actively pursued by manufacturers. Psoriasis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for Psoriasis by pathway target and mechanism of action. Pipeline Analysis by Pathway Target and Mechanism ... \| more... Search inside this report	$8,500.00
Psoriasis Pipeline Perspectives Report - Direct Inflammatory Cytokine Blockers 7/1/2012 \| published by: Pharmspective ... are being actively pursued by manufacturers. Psoriasis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for Psoriasis by pathway target and mechanism of action. Pipeline Analysis by Pathway Target and Mechanism ... \| more... Search inside this report	$1,500.00
Psoriasis Pipeline Perspectives Report - T-cell Activation Blockers 7/1/2012 \| published by: Pharmspective ... are being actively pursued by manufacturers. Psoriasis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for Psoriasis by pathway target and mechanism of action. Pipeline Analysis by Pathway Target and Mechanism ... \| more... Search inside this report	$1,500.00
Psoriasis Pipeline Perspectives Report - T-cell Migration Blockers 7/1/2012 \| published by: Pharmspective ... are being actively pursued by manufacturers. Psoriasis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for Psoriasis by pathway target and mechanism of action. Pipeline Analysis by Pathway Target and Mechanism ... \| more... Search inside this report	$1,500.00
Psoriasis Pipeline Perspectives Report - Inflammatory Cytokine Blockers 7/1/2012 \| published by: Pharmspective ... are being actively pursued by manufacturers. Psoriasis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for Psoriasis by pathway target and mechanism of action. Pipeline Analysis by Pathway Target and Mechanism ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - Inflammatory Cytokine Production Inhibitors 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - T-cell Migration Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - B-cell Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Molecular Diagnostics Insights in Oncology: Breast Cancer 6/1/2012 \| published by: Pharmspective ... hope of optimizing treatment outcomes and has spawned the emergence of companion diagnostics in oncology. Pharmspective’s Molecular Diagnostics Insights in Oncology: Breast Cancer evaluates the emerging molecular diagnostics landscape and its role and influence in ... \| more... Search inside this report	$8,500.00
Molecular Diagnostics Insights in Oncology: Lung Cancer 6/1/2012 \| published by: Pharmspective ... hope of optimizing treatment outcomes and has spawned the emergence of companion diagnostics in oncology. Pharmspective’s Molecular Diagnostics Insights in Oncology: Lung Cancer evaluates the emerging molecular diagnostics landscape and its role and influence in ... \| more... Search inside this report	$8,500.00
Molecular Diagnostics Insights in Oncology: Colorectal Cancer 6/1/2012 \| published by: Pharmspective ... hope of optimizing treatment outcomes and has spawned the emergence of companion diagnostics in oncology. Pharmspective’s Molecular Diagnostics Insights in Oncology: Colorectal Cancer evaluates the emerging molecular diagnostics landscape and its role and influence in ... \| more... Search inside this report	$8,500.00
Molecular Diagnostics Insights in Oncology: Breast, Colorectal, Lung, Prostate and Melanoma 6/1/2012 \| published by: Pharmspective ... hope of optimizing treatment outcomes and has spawned the emergence of companion diagnostics in oncology. Pharmspective’s Molecular Diagnostics Insights in Oncology Report evaluates the emerging molecular diagnostics landscape and its role and influence in decisions ... \| more... Search inside this report	$40,000.00
Molecular Diagnostics Insights in Oncology: Melanoma 6/1/2012 \| published by: Pharmspective ... hope of optimizing treatment outcomes and has spawned the emergence of companion diagnostics in oncology. Pharmspective’s Molecular Diagnostics Insights in Oncology: Melanoma evaluates the emerging molecular diagnostics landscape and its role and influence in decisions ... \| more... Search inside this report	$8,500.00
Molecular Diagnostics Insights in Oncology: Prostate Cancer 6/1/2012 \| published by: Pharmspective ... hope of optimizing treatment outcomes and has spawned the emergence of companion diagnostics in oncology. Pharmspective’s Molecular Diagnostics Insights in Oncology: Prostate Cancer evaluates the emerging molecular diagnostics landscape and its role and influence in ... \| more... Search inside this report	$8,500.00
Prescribing Trends and Treatment Algorithms in Rheumatoid Arthritis 4/1/2012 \| published by: Pharmspective ... and prescribing scrutiny surrounding expensive specialty drugs. Pharmspective’s Prescribing Trends and Treatment Algorithms in Rheumatoid Arthritis is part of a larger report (Rheumatoid Arthritis Adoption Insights) that is designed to provide a different perspective on ... \| more...	$6,500.00

< prev 1 2 next >

Pharmspective

List of reports from Pharmspective

Research assistance

Join Alert Me now!